financetom
Business
financetom
/
Business
/
MOVES-Citi names Tokiya Kishie as Japan markets head
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MOVES-Citi names Tokiya Kishie as Japan markets head
Sep 26, 2024 11:26 PM

TOKYO, Sept 26 (Reuters) - Citigroup ( C/PN ) has appointed

Tokiya Kishie as its new head of markets for Japan, it said in a

statement on Thursday.

Kishie joined Citi in 2010 after working at Nomura

Securities, Lehman Brothers and Tokyo Star Bank.

At Citi he has worked in various positions in Tokyo, New

York and London and was most recently head of fixed income

structuring for Japan, based in Tokyo.

Kishie's appointment will be effective Oct. 1, 2024, and he

will report to Paul Smith, head of markets for Citi's Japan,

Asia North and Australia cluster, and Robert Nakamura, country

officer and banking head for Japan.

(Reporting by Anton Bridge; Editing by Mrigank Dhaniwala)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US beef sales to China skid after Beijing lets export registrations lapse
US beef sales to China skid after Beijing lets export registrations lapse
Mar 27, 2025
CHICAGO, March 27 (Reuters) - U.S. beef sales to China have taken a dive, U.S. government data showed on Thursday, after Beijing allowed the expiration of registrations that had permitted exports from hundreds of American meat facilities. A tit-for-tat tariff dispute has also raised duties on U.S. meat and other goods shipped to China, making the products less attractive to...
Tesla, Rivian Likely to Fare Better Amid US Tariffs, UBS Says
Tesla, Rivian Likely to Fare Better Amid US Tariffs, UBS Says
Mar 27, 2025
03:08 PM EDT, 03/27/2025 (MT Newswires) -- Tesla (TSLA) and Rivian Automotive ( RIVN ) are likely to fare better after President Donald Trump signed an executive order placing a 25% tariff on automobiles and parts imported to the US, UBS said in a Thursday report. We believe TSLA and RIVN could fare better as 100% of their production is...
Update: Sen. Ron Wyden Accuses Pfizer of Tax Dodging After Concluding Investigation
Update: Sen. Ron Wyden Accuses Pfizer of Tax Dodging After Concluding Investigation
Mar 27, 2025
02:52 PM EDT, 03/27/2025 (MT Newswires) -- (Update with Pfizer's ( PFE ) response to a request for comment.) Pfizer ( PFE ) sold $20 billion of drugs to US patients in 2019, but reported zero taxable profits by claiming that 100% of the profits were earned offshore, according to the findings of an investigation conducted by Senate Finance Committee...
Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan
Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan
Mar 27, 2025
JPMorgan initiated coverage on Ascentage Pharma Group ( AAPG ) , a commercial-stage Chinese biotech company focusing on cancer treatment. In January, Ascentage Pharma’s American depositary shares started trading after the company closed its U.S. initial public offering of 7.325 million ADS at $17.25 per ADS. On Wednesday, JP Morgan said the company’s valuation is largely driven by two late-stage assets...
Copyright 2023-2026 - www.financetom.com All Rights Reserved